Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

CervoMed Inc.

NASDAQ: CRVO · Life Sciences · 8 alerts · CIK 1053691

Share price
$1.67Close, Nov 16
Market cap
$25.3M
Shares outstanding
15.13MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CervoMed Inc. filings on SEC EDGAR ↗

5:09 PM ET 8-K
Business Update

CervoMed Business Update

CervoMed announced pharmacokinetic and regulatory updates for its lead drug candidate, neflamapimod, including a new 50 mg oral tablet formulation and the FDA's removal of a previous drug exposure limit. These developments allow the company to advance a 100 mg twice-daily dosing regimen in future clinical trials, which is expected to achieve higher drug concentrations and improve patient convenience compared to prior three-times-daily dosing.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.